Shares of Monsanto Co. (NYSE:MON) have received an average recommendation of “Buy” from the twenty-six ratings firms that are covering the company. Three analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation, fourteen have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $112.85.

A number of research analysts have recently issued reports on the stock. Argus reiterated a “buy” rating and set a $128.00 price objective on shares of Monsanto in a report on Sunday, October 9th. BMO Capital Markets reiterated an “outperform” rating and set a $128.00 price objective on shares of Monsanto in a report on Saturday, October 8th. JPMorgan Chase & Co. set a $128.00 price objective on shares of Monsanto and gave the company a “buy” rating in a report on Thursday, October 6th. Zacks Investment Research cut shares of Monsanto from a “hold” rating to a “strong sell” rating in a report on Friday, October 7th. Finally, Deutsche Bank AG reiterated a “buy” rating on shares of Monsanto in a report on Thursday, October 6th.

Monsanto (NYSE:MON) opened at 97.90 on Wednesday. The firm has a 50-day moving average of $101.48 and a 200 day moving average of $103.35. The company has a market capitalization of $42.88 billion, a PE ratio of 32.76 and a beta of 1.01. Monsanto has a 12-month low of $83.73 and a 12-month high of $114.26.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same period in the previous year, the firm posted ($0.19) earnings per share. The business’s revenue was up 8.8% compared to the same quarter last year. Analysts forecast that Monsanto will post $4.73 EPS for the current fiscal year.

In other news, EVP Robert T. Fraley sold 80,631 shares of the stock in a transaction on Friday, October 14th. The shares were sold at an average price of $102.04, for a total value of $8,227,587.24. Following the transaction, the executive vice president now owns 38,711 shares of the company’s stock, valued at approximately $3,950,070.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Steven Mizell sold 310 shares of the stock in a transaction on Monday, October 10th. The stock was sold at an average price of $103.09, for a total transaction of $31,957.90. The disclosure for this sale can be found here. Corporate insiders own 0.88% of the company’s stock.

Several institutional investors have recently modified their holdings of MON. WFG Advisors LP raised its position in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the last quarter. Signaturefd LLC raised its position in shares of Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the last quarter. Mycio Wealth Partners LLC raised its position in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the last quarter. Pinkerton Retirement Specialists LLC raised its position in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the last quarter. Finally, Enterprise Financial Services Corp raised its position in shares of Monsanto by 4.5% in the second quarter. Enterprise Financial Services Corp now owns 1,335 shares of the company’s stock worth $138,000 after buying an additional 57 shares during the last quarter. 78.72% of the stock is currently owned by hedge funds and other institutional investors.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.